Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Accepts Investigational New Drug Application for COMP360 for PTSD
2
New Phase 3 Clinical Vocal Biomarker Data on Brilaroxazine to Treat Negative Symptoms in Schizophrenia
3
Accident, or Is It? The Watershed Area Between Trauma and Suicide
4
FDA Grants Breakthrough Therapy Designation to Alixorexton for the Treatment of Narcolepsy Type 1
5